Avandaryl rosiglitazone/glimepiride regulatory update

GSK added a boxed warning to the label for Avandaryl rosiglitazone/glimepiride to warn of the risk of congestive heart failure (CHF) and highlight the fact that the diabetes drug is not recommended in...